Replies to post #7605 on Cellectar Biosciences Inc (CLRB)

[headsortails2066]

I mean revenue.

Read toward the middle of this release.

Cellectar’s CLR 131 Receives FDA Rare Pediatric Disease Designation for the Treatment of Ewing’s Sarcomahttps://finance.yahoo.com/news/cellectar-clr-131-receives-fda-120000936.html